Acid β-glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α-synuclein processing
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acid β-glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α-synuclein processing
Authors
Keywords
-
Journal
ANNALS OF NEUROLOGY
Volume 69, Issue 6, Pages 940-953
Publisher
Wiley
Online
2011-02-18
DOI
10.1002/ana.22400
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intracerebroventricular delivery of glucocerebrosidase reduces substrates and increases lifespan in a mouse model of neuronopathic Gaucher disease
- (2010) M.A. Cabrera-Salazar et al. EXPERIMENTAL NEUROLOGY
- Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated α-synuclein gene mutations precede central nervous system changes
- (2010) Yien-Ming Kuo et al. HUMAN MOLECULAR GENETICS
- Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits
- (2010) Y. Sun et al. HUMAN MOLECULAR GENETICS
- Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease
- (2010) I. Ron et al. HUMAN MOLECULAR GENETICS
- Association of Glucocerebrosidase Mutations With Dementia With Lewy Bodies
- (2009) Lorraine N. Clark et al. ARCHIVES OF NEUROLOGY
- Expansion of the Parkinson disease-associated SNCA- Rep1 allele upregulates human α-synuclein in transgenic mouse brain
- (2009) Kenneth D. Cronin et al. HUMAN MOLECULAR GENETICS
- Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: A biological link between Gaucher disease and parkinsonism
- (2009) Amy B. Manning-Boğ et al. NEUROTOXICOLOGY
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
- (2009) E. Sidransky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo
- (2009) Valerie Cullen et al. Molecular Brain
- Glucocerebrosidase Gene Mutations
- (2008) Ignacio F. Mata et al. ARCHIVES OF NEUROLOGY
- Cathepsin D Is the Main Lysosomal Enzyme Involved in the Degradation of α-Synuclein and Generation of Its Carboxy-Terminally Truncated Species†
- (2008) Daniel Sevlever et al. BIOCHEMISTRY
- Optimization and Validation of Two Miniaturized Glucocerebrosidase Enzyme Assays for High Throughput Screening
- (2008) Daniel Urban et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
- (2008) Brit Mollenhauer et al. EXPERIMENTAL NEUROLOGY
- Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease
- (2008) Jose Bras et al. FEBS Journal
- GATA transcription factors directly regulate the Parkinson's disease-linked gene -synuclein
- (2008) C. R. Scherzer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity
- (2008) Liyan Qiao et al. Molecular Brain
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started